Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Care Facilities

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
Website: lifestance.com



Growth: Good revenue growth rate 16.3%, there is acceleration compared to average historical growth rates 13.4%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is positive, +4.6%. On average the margin is improving steadily. Gross margin is normal, +32.0%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 60% of quarters (showing a gain of $0 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 4.5% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 92.9% higher than minimum and 22.2% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.4x by EV / Sales multiple , the company can be 8.4% undervalued

Insiders: For the last 3 months insiders sold company shares on $2.3 mln (-0.085% of cap.)

Key Financials (Download financials)

Ticker: LFST
Share price, USD:  (0.0%)7.31
year average price 6.06  


year start price 7.91 2025-02-07

max close price 8.16 2025-03-05

min close price 3.79 2025-08-01

current price 7.31 2026-02-06
Common stocks: 386 963 000

Dividend Yield:  0.0%
FCF Yield LTM: 4.5%
EV / LTM EBITDA: 49.0x
EV / EBITDA annualized: 36.7x
Last revenue growth (y/y):  +16.3%
Last growth of EBITDA (y/y):  +40.0%
Historical revenue growth:  +13.4%
Historical growth of EBITDA:  +99.2%
EV / Sales: 2.3x
Margin (EBITDA LTM / Revenue): 4.6%
Fundamental value created in LTM:
Market Cap ($m): 2 829
Net Debt ($m): 257
EV (Enterprise Value): 3 086
Price to Book: 1.9x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2025-11-28zacks.com

Wall Street Analysts Think LifeStance Health (LFST) Could Surge 30.49%: Read This Before Placing a Bet

2025-11-12zacks.com

Wall Street Analysts See a 33.38% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?

2025-11-06seekingalpha.com

LifeStance Health Group, Inc. (LFST) Q3 2025 Earnings Call Transcript

2025-11-06zacks.com

LifeStance Health Group (LFST) Reports Break-Even Earnings for Q3

2025-09-09seekingalpha.com

LifeStance Health Group, Inc. (LFST) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

2025-08-08seekingalpha.com

LifeStance Health Group, Inc. (LFST) Q2 2025 Earnings Call Transcript

2025-08-07zacks.com

LifeStance Health Group (LFST) Reports Q2 Loss, Tops Revenue Estimates

2025-08-07globenewswire.com

LifeStance Reports Second Quarter 2025 Results

2025-07-17globenewswire.com

LifeStance to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025

2025-07-03seekingalpha.com

LifeStance: First Profit, Expanding Margins, And Hybrid Model Make It A Buy Despite Valuation Concerns
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-12-31 2020-12-31
symbol LFST LFST LFST LFST LFST LFST LFST LFST LFST LFST LFST LFST LFST LFST LFST
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-06 2025-08-07 2024-11-07 2024-08-08 2024-05-09 2023-11-08 2023-08-09 2023-05-10 2022-11-09 2022-08-10
acceptedDate 2025-11-06 16:29:44 2025-08-07 16:29:09 2025-02-27 16:26:15 2024-11-07 16:15:58 2024-08-08 16:35:25 2024-05-09 16:15:12 2024-02-28 21:23:00 2023-11-08 16:12:12 2023-08-09 16:26:18 2023-05-10 16:17:23 2023-03-09 16:10:58 2022-11-09 16:22:07 2022-08-10 16:37:25 2022-03-17 16:21:23 2020-12-31 00:00:00
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
revenue 364M 345M 1 251M 313M 312M 300M 1 056M 263M 260M 253M 860M 218M 210M 668M 377M
costOfRevenue 247M 251M 849M 212M 233M 228M 754M 187M 187M 183M 623M 157M 150M 466M 243M
grossProfit 117M 94M 402M 100M 79M 72M 302M 76M 73M 70M 237M 60M 60M 202M 134M
grossProfitRatio 0.32 0.273 0.321 0.254 0.24 0.29 0.281 0.276 0.277 0.286
researchAndDevelopmentExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
generalAndAdministrativeExpenses 96M 97M 363M 85M 95M 89M 411M 131M 102M 85M 378M 81M 104M 434M 88M
sellingAndMarketingExpenses 0 0 0 0 -381 000 -95 000 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 96M 97M 363M 85M 95M 89M 411M 131M 102M 85M 378M 81M 104M 434M 88M
otherExpenses 13M 0 71M 15M -4000 -74 000 80M -1000 -24 000 19M 69M 18M 17M 54M 31M
operatingExpenses 109M 97M 434M 100M 95M 89M 491M 151M 121M 104M 447M 99M 120M 488M 119M
costAndExpenses 356M 348M 1 283M 313M 328M 317M 1 245M 337M 308M 287M 1 070M 256M 270M 954M 362M
interestIncome 0 0 0 0 0 0 0 5M 5M 0 0 0 0 0 22M
interestExpense 3M 3M 27M 5M 6M 6M 21M 5M 5M 5M 20M 4M 7M 39M 22M
depreciationAndAmortization 14M 14M 71M 15M 19M 23M 80M 20M 20M 19M 69M 18M 17M 54M 31M
ebitda 21M 11M 40M 15M 2M 6M -105M -55M -29M -15M -144M -21M -44M -240M 9M
ebitdaratio 0.058 0.032 0.048 0.01 0.02 -0.208 -0.111 -0.06 -0.097 -0.21
operatingIncome 7M -3M -32M 47 000 -16M -17M -189M -74M -48M -34M -210M -39M -60M -286M 15M
operatingIncomeRatio 0.02 -0.009 0 -0.05 -0.056 -0.283 -0.187 -0.135 -0.179 -0.289
totalOtherIncomeExpensesNet -3M -3M -26M -5M -7M -4M -17M 2M 2M -4M -23M -3M -199 000 -47M -60M
incomeBeforeTax 5M -6M -58M -5M -23M -21M -207M -78M -52M -38M -233M -42M -68M -333M -44M
incomeBeforeTaxRatio 0.013 -0.017 -0.017 -0.072 -0.069 -0.297 -0.2 -0.152 -0.194 -0.324
incomeTaxExpense 3M -2M -170 000 575 000 656 000 363 000 -20M -16M -7M -4M -17M -4M 923 000 -26M -6M
netIncome 1M -4M -57M -6M -23M -21M -186M -62M -45M -34M -216M -38M -69M -307M -38M
netIncomeRatio 0.003 -0.011 -0.019 -0.075 -0.07 -0.234 -0.175 -0.136 -0.174 -0.328
eps 0.003 -0.01 -0.15 -0.016 -0.061 -0.056 -0.51 -0.17 -0.13 -0.095 -0.61 -0.11 -0.19 -1.05 -0.83
epsdiluted 0.003 -0.01 -0.016 -0.061 -0.056 -0.17 -0.13 -0.095 -0.11 -0.19
weightedAverageShsOut 387M 385M 379M 379M 379M 376M 367M 372M 363M 361M 355M 358M 354M 328M 374M
weightedAverageShsOutDil 389M 385M 379M 379M 379M 376M 367M 372M 363M 361M 355M 358M 354M 328M 374M
link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-28 2023-03-09 2022-03-17 2020-12-31
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -27M -21M -20M -39M 0
ebit -31M -185M -213M -294M -22M
nonOperatingIncomeExcludingInterest -535 000 -4M 3M 8M 38M
netIncomeFromContinuingOperations -57M -186M -216M -307M -38M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -57M -186M -216M -344M -311M
epsDiluted -0.15 -0.51 -0.61 -1.05 -0.83

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-12-31 2020-12-31
symbol LFST LFST LFST LFST LFST LFST LFST LFST LFST LFST LFST LFST LFST LFST LFST
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-06 2025-08-07 2024-11-07 2024-08-08 2024-05-09 2023-11-08 2023-08-09 2023-05-10 2022-11-09 2022-08-10
acceptedDate 2025-11-06 16:29:44 2025-08-07 16:29:09 2025-02-27 16:26:15 2024-11-07 16:15:58 2024-08-08 16:35:25 2024-05-09 16:15:12 2024-02-28 21:23:00 2023-11-08 16:12:12 2023-08-09 16:26:18 2023-05-10 16:17:23 2023-03-09 16:10:58 2022-11-09 16:22:07 2022-08-10 16:37:25 2022-03-17 16:21:23 2020-12-31 00:00:00
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
cashAndCashEquivalents 204M 189M 155M 103M 87M 49M 79M 43M 80M 68M 109M 90M 97M 148M 19M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 204M 189M 155M 103M 87M 49M 79M 43M 80M 68M 109M 90M 97M 148M 19M
netReceivables 121M 129M 132M 158M 167M 176M 126M 150M 122M 118M 102M 113M 100M 99M 44M
inventory 0 0 0 0 0 1 0 0 0 0 0 0 0 38M 0
otherCurrentAssets 35M 40M 15M 26M 24M 19M 11M 72M 36M 26M 11M 49M 48M -26M 8M
totalCurrentAssets 360M 359M 313M 287M 278M 244M 226M 264M 238M 213M 233M 253M 244M 267M 76M
propertyPlantEquipmentNet 308M 304M 314M 325M 336M 348M 359M 371M 385M 390M 394M 193M 191M 152M 59M
goodwill 1 293M 1 293M 1 293M 1 293M 1 293M 1 293M 1 293M 1 293M 1 294M 1 294M 1 273M 1 250M 1 244M 1 205M 1 099M
intangibleAssets 181M 184M 191M 195M 200M 209M 221M 234M 244M 254M 263M 272M 282M 300M 333M
goodwillAndIntangibleAssets 1 474M 1 477M 1 484M 1 489M 1 493M 1 502M 1 514M 1 527M 1 537M 1 548M 1 536M 1 522M 1 526M 1 505M 1 431M
longTermInvestments 0 0 0 0 4M 4M 0 6M 6M 0 0 0 0 -43M -11M
taxAssets 0 0 0 0 0 -4M 0 -6M -6M 0 0 0 0 43M 11M
otherNonCurrentAssets 6M 7M 8M 7M 8M 12M 11M 13M 11M 9M 11M 11M 8M 3M 3M
totalNonCurrentAssets 1 789M 1 788M 1 806M 1 821M 1 842M 1 862M 1 884M 1 911M 1 933M 1 946M 1 941M 1 727M 1 724M 1 661M 1 493M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 2 149M 2 147M 2 118M 2 108M 2 119M 2 106M 2 110M 2 175M 2 171M 2 159M 2 174M 1 980M 1 969M 1 927M 1 570M
accountPayables 12M 8M 7M 7M 10M 12M 23M 10M 8M 8M 24M 8M 13M 14M 8M
shortTermDebt 60M 58M 7M 49M 52M 53M 3M 44M 43M 42M 2M 0 0 1M 4M
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0 446 000
deferredRevenue 0 0 0 0 0 0 0 175M 115M 0 0 0 0 76M 0
otherCurrentLiabilities 156M 177M 19M 161M 166M 143M 9M 12M 14M 132M 16M 104M 99M -51M 19M
totalCurrentLiabilities 229M 242M 229M 218M 228M 207M 203M 241M 181M 181M 176M 112M 112M 117M 76M
longTermDebt 414M 416M 280M 438M 445M 280M 280M 440M 454M 433M 225M 212M 203M 157M 363M
deferredRevenueNonCurrent 0 0 0 0 166M 173M 0 0 0 0 0 0 0 0 35M
deferredTaxLiabilitiesNonCurrent 0 14M 14M 15M 16M 16M 16M 38M 38M 38M 39M 55M 54M 54M 81M
otherNonCurrentLiabilities 14M 182 000 309 000 381 000 571 000 760 000 952 000 855 000 3M 2M 3M 328M 68M 54M 17M
totalNonCurrentLiabilities 428M 431M 443M 453M 462M 470M 478M 479M 495M 472M 479M 336M 326M 265M 496M
otherLiabilities 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 192M 191M 198M 208M 215M 173M 228M 235M 249M 250M 251M 0 0 0 0
totalLiabilities 656M 673M 672M 671M 689M 677M 681M 720M 676M 653M 655M 448M 437M 382M 572M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0 35M
commonStock 4M 4M 4M 4M 4M 4M 4M 4M 4M 4M 4M 4M 4M 4M 1 010M
retainedEarnings -820M -821M -818M -811M -805M -782M -761M -716M -654M -609M -573M -526M -488M -357M -13M
accumulatedOtherComprehensiveIncomeLoss -0 345 000 929 000 771 000 3M 3M 2M 4M 4M 2M 3M 3M 0 0 -35M
othertotalStockholdersEquity 2 309M 2 291M 2 244M 2 229M 2 204M 2 163M 2 141M 2 108M 2 051M 2 016M
totalStockholdersEquity 1 493M 1 474M 1 446M 1 437M 1 430M 1 429M 1 429M 1 455M 1 495M 1 505M 1 519M 1 532M 1 531M 1 545M 998M
totalEquity 1 493M 1 474M 1 446M 1 437M 1 430M 1 429M 1 429M 1 455M 1 495M 1 505M 1 519M 1 532M 1 531M 1 545M 998M
totalLiabilitiesAndStockholdersEquity 2 149M 2 147M 2 108M 2 119M 2 106M 2 175M 2 171M 2 159M 1 980M 1 969M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 2 149M 2 147M 2 118M 2 108M 2 119M 2 106M 2 110M 2 175M 2 171M 2 159M 2 174M 1 980M 1 969M 1 927M 1 570M
totalInvestments 0 0 0 0 4M 4M 0 6M 6M 0 0 0 0 -43M -11M
totalDebt 474M 474M 485M 487M 497M 506M 511M 483M 498M 474M 479M 212M 203M 159M 366M
netDebt 270M 285M 331M 384M 410M 456M 432M 441M 418M 406M 370M 122M 107M 11M 347M
link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-28 2023-03-09 2022-03-17 2020-12-31
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 132M 125M 101M 76M 44M
otherReceivables 223 000 235 000 640 000 23M 0
prepaids 11M 11M 12M 7M 6M
totalPayables 7M 23M 24M 14M 8M
otherPayables 0 0 0 0 0
accruedExpenses 146M 121M 94M 76M 45M
capitalLeaseObligationsCurrent 49M 46M 39M 0 0
capitalLeaseObligationsNonCurrent 149M 181M 213M 0 0
treasuryStock 0 0 0 0 0
additionalPaidInCapital 2 260M 2 184M 2 084M 1 898M 1M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-12-31 2020-12-31
symbol LFST LFST LFST LFST LFST LFST LFST LFST LFST LFST LFST LFST LFST LFST LFST
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-06 2025-08-07 2024-11-07 2024-08-08 2024-05-09 2023-11-08 2023-08-09 2023-05-10 2022-11-09 2022-08-10
acceptedDate 2025-11-06 16:29:44 2025-08-07 16:29:09 2025-02-27 16:26:15 2024-11-07 16:15:58 2024-08-08 16:35:25 2024-05-09 16:15:12 2024-02-28 21:23:00 2023-11-08 16:12:12 2023-08-09 16:26:18 2023-05-10 16:17:23 2023-03-09 16:10:58 2022-11-09 16:22:07 2022-08-10 16:37:25 2022-03-17 16:21:23 2020-12-31 00:00:00
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
netIncome 1M -4M -57M -6M -23M -21M -186M -62M -45M -34M -216M -38M -69M -307M -38M
depreciationAndAmortization 14M 14M 71M 15M 19M 23M 80M 20M 20M 19M 69M 18M 17M 54M 31M
deferredIncomeTax 0 0 -958 000 -656 000 656 000 0 -22M -16M -7M 0 -17M 0 0 -27M 0
stockBasedCompensation 18M 21M 76M 15M 25M 21M 99M 22M 33M 24M 187M 35M 58M 259M 1M
changeInWorkingCapital -17M 22M -27M 38M 14M -52M -34M -16M -19M -26M -17M -9M -2M 2M -753 000
accountsReceivables 8M 11M -6M 9M 9M -51M -24M -28M -3M -17M -22M -13M -4M -24M -13M
inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
accountsPayables 3M -200 000 501 000 -3M -2M 5M -6M 2M 71 000 -5M 8M -622 000 -121 000 623 000 829 000
otherWorkingCapital -29M 11M -21M 32M 7M -6M -4M 10M -16M -4M -3M 5M 0 26M 12M
otherNonCashItems 12M 11M 46M -39M 65M 119M 45M 27M 18M 10M 45M -429 000 4M 28M -2M
netCashProvidedByOperatingActivities 27M 64M 107M 23M 44M -22M -17M -25M -434 000 -8M 53M 6M 8M 9M -9M
investmentsInPropertyPlantAndEquipment -10M -8M -22M -5M -5M -5M -41M -10M -12M -8M -79M -15M -26M -94M -38M
acquisitionsNet 0 0 0 0 0 0 -20M 0 0 -20M -60M -5M -12M -100M -823M
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherInvestingActivites 0 0 0 0 0 0 0 0 0 0
netCashUsedForInvestingActivites -10M -8M -5M -5M -5M -10M -12M -28M -20M -38M
debtRepayment -2M -2M -731 000 -732 000 -731 000 -648 000 -587 000 -586 000 0 -181M
commonStockIssued 0 0 0 0 0 0 0 0 0 0
commonStockRepurchased 0 -236 000 0 0 0 0 0 0 0 0 -904 000 0 0 0 -1 000 000
dividendsPaid 0 0 0 0 0 0 0 0 0 0
otherFinancingActivites -209 000 0 -1M -700 000 -2M -1M 24M -4M 8M 194M
netCashUsedProvidedByFinancingActivities -2M -2M -2M -1M -2M -2M 23M -5M 8M 13M
effectOfForexChangesOnCash 0 0 0 0 0 0 0 57M 8M 0 0 0 0 0 -27M
netChangeInCash 15M 55M 76M 16M 38M -29M -30M -37M 11M -40M -39M -6M -17M 129M 15M
cashAtEndOfPeriod 204M 189M 155M 103M 87M 49M 79M 43M 80M 68M 109M 90M 97M 148M 19M
cashAtBeginningOfPeriod 189M 134M 79M 87M 49M 79M 109M 80M 68M 109M 148M 97M 114M 19M 3M
operatingCashFlow 27M 64M 107M 23M 44M -22M -17M -25M -434 000 -8M 53M 6M 8M 9M -9M
capitalExpenditure -10M -8M -22M -5M -5M -5M -41M -10M -12M -8M -79M -15M -26M -94M -38M
freeCashFlow 17M 57M 86M 18M 39M -27M -57M -35M -12M -16M -26M -9M -18M -85M -47M
link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-28 2023-03-09 2022-03-17 2020-12-31
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 0 0 0 0 0
netCashProvidedByInvestingActivities -22M -60M -139M -194M -861M
netDebtIssuance -2M 55M 70M -224M 291M
longTermNetDebtIssuance -2M 55M 70M -221M 291M
shortTermNetDebtIssuance 0 0 0 -2M 0
netStockIssuance 0 0 -904 000 550M 20M
netCommonStockIssuance 0 0 -904 000 550M 20M
commonStockIssuance 0 0 0 550M 21M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -8M -8M -21M -12M 601M
netCashProvidedByFinancingActivities -10M 47M 47M 314M 912M
incomeTaxesPaid 57 000 80 000 2M 1M 0
interestPaid 25M 21M 14M 22M 0

Earning call transcript

2025 q3
2025-11-06 ET (fiscal 2025 q3)
2025 q2
2025-08-08 ET (fiscal 2025 q2)
2025 q1
2025-05-10 ET (fiscal 2025 q1)
2024 q4
2025-02-28 ET (fiscal 2024 q4)
2024 q2
2024-08-08 ET (fiscal 2024 q2)
2024 q1
2024-05-11 ET (fiscal 2024 q1)
2023 q4
2024-02-28 ET (fiscal 2023 q4)
2023 q3
2023-11-11 ET (fiscal 2023 q3)
2023 q2
2023-08-09 ET (fiscal 2023 q2)
2023 q1
2023-05-13 ET (fiscal 2023 q1)
2022 q4
2023-03-08 ET (fiscal 2022 q4)
2022 q3
2022-11-13 ET (fiscal 2022 q3)
2022 q2
2022-08-13 ET (fiscal 2022 q2)
2022 q1
2022-05-09 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-11-06 21:29 ET
LifeStance Health Group, Inc. reported for 2025 q3
SEC form 8
2025-11-05 23:41 ET
LifeStance Health Group, Inc. published news for 2025 q3
SEC form 8
2025-11-05 23:41 ET
LifeStance Health Group, Inc. published news for 2025 q3
SEC form 8
2025-11-05 23:41 ET
LifeStance Health Group, Inc. published news for 2025 q3
SEC form 10
2025-08-07 20:29 ET
LifeStance Health Group, Inc. reported for 2025 q2
SEC form 8
2025-08-06 23:03 ET
LifeStance Health Group, Inc. published news for 2025 q2
SEC form 8
2025-08-06 23:03 ET
LifeStance Health Group, Inc. published news for 2025 q2
SEC form 8
2025-08-06 23:03 ET
LifeStance Health Group, Inc. published news for 2025 q2
SEC form 10
2025-05-07 20:42 ET
LifeStance Health Group, Inc. reported for 2025 q1
SEC form 10
2025-05-07 00:00 ET
LifeStance Health Group, Inc. published news for 2025 q1
SEC form 8
2025-05-06 22:33 ET
LifeStance Health Group, Inc. published news for 2025 q1
SEC form 8
2025-05-06 22:33 ET
LifeStance Health Group, Inc. published news for 2025 q1
SEC form 8
2025-05-06 22:33 ET
LifeStance Health Group, Inc. published news for 2025 q1
SEC form 10
2025-02-27 16:26 ET
LifeStance Health Group, Inc. reported for 2024 q4
SEC form 10
2025-02-27 00:00 ET
LifeStance Health Group, Inc. published news for 2024 q4
SEC form 8
2025-02-26 18:51 ET
LifeStance Health Group, Inc. published news for 2024 q4
SEC form 8
2025-02-26 18:51 ET
LifeStance Health Group, Inc. published news for 2024 q4
SEC form 8
2025-02-26 18:51 ET
LifeStance Health Group, Inc. published news for 2024 q4
SEC form 10
2024-11-07 16:15 ET
LifeStance Health Group, Inc. published news for 2024 q3
SEC form 8
2024-11-06 18:34 ET
LifeStance Health Group, Inc. published news for 2024 q3
SEC form 8
2024-11-06 18:34 ET
LifeStance Health Group, Inc. published news for 2024 q3
SEC form 8
2024-11-06 18:34 ET
LifeStance Health Group, Inc. published news for 2024 q3
SEC form 10
2024-08-08 16:35 ET
LifeStance Health Group, Inc. published news for 2024 q2
SEC form 10
2024-08-08 00:00 ET
LifeStance Health Group, Inc. published news for 2024 q2
SEC form 8
2024-08-07 18:42 ET
LifeStance Health Group, Inc. published news for 2024 q2
SEC form 8
2024-08-07 18:42 ET
LifeStance Health Group, Inc. reported for 2024 q2
SEC form 8
2024-08-07 18:42 ET
LifeStance Health Group, Inc. published news for 2024 q2
SEC form 10
2024-05-09 00:00 ET
LifeStance Health Group, Inc. published news for 2024 q1
SEC form 8
2024-05-09 00:00 ET
LifeStance Health Group, Inc. published news for 2024 q1
SEC form 8
2024-05-09 00:00 ET
LifeStance Health Group, Inc. reported for 2024 q1
SEC form 8
2024-05-09 00:00 ET
LifeStance Health Group, Inc. published news for 2024 q1
SEC form 10
2024-02-28 16:23 ET
LifeStance Health Group, Inc. published news for 2023 q4
SEC form 10
2024-02-28 00:00 ET
LifeStance Health Group, Inc. published news for 2023 q4
SEC form 8
2024-02-27 18:39 ET
LifeStance Health Group, Inc. published news for 2023 q4
SEC form 8
2024-02-27 18:39 ET
LifeStance Health Group, Inc. reported for 2023 q4
SEC form 8
2024-02-27 18:39 ET
LifeStance Health Group, Inc. published news for 2023 q4
SEC form 8
2024-02-02 00:00 ET
LifeStance Health Group, Inc. published news for 2023 q4
SEC form 10
2023-11-08 16:12 ET
LifeStance Health Group, Inc. published news for 2023 q3
SEC form 10
2023-11-08 00:00 ET
LifeStance Health Group, Inc. published news for 2023 q3
SEC form 8
2023-11-07 18:27 ET
LifeStance Health Group, Inc. reported for 2023 q3
SEC form 10
2023-08-09 16:26 ET
LifeStance Health Group, Inc. published news for 2023 q2
SEC form 10
2023-08-09 00:00 ET
LifeStance Health Group, Inc. published news for 2023 q2
SEC form 8
2023-08-09 00:00 ET
LifeStance Health Group, Inc. published news for 2023 q2
SEC form 6
2023-08-08 18:40 ET
LifeStance Health Group, Inc. reported for 2023 q2
SEC form 10
2023-05-10 00:00 ET
LifeStance Health Group, Inc. published news for 2023 q1
SEC form 8
2023-05-10 00:00 ET
LifeStance Health Group, Inc. published news for 2023 q1
SEC form 10
2023-03-09 16:10 ET
LifeStance Health Group, Inc. reported for 2022 q4
SEC form 10
2023-03-09 00:00 ET
LifeStance Health Group, Inc. reported for 2022 q4
SEC form 8
2023-03-08 00:00 ET
LifeStance Health Group, Inc. reported for 2022 q4
SEC form 6
2023-03-07 18:52 ET
LifeStance Health Group, Inc. reported for 2022 q4
SEC form 6
2023-02-13 16:41 ET
LifeStance Health Group, Inc. published news for 2022 q4
SEC form 6
2022-11-14 17:18 ET
LifeStance Health Group, Inc. published news for 2022 q3
SEC form 10
2022-11-09 16:22 ET
LifeStance Health Group, Inc. reported for 2022 q3
SEC form 10
2022-11-09 00:00 ET
LifeStance Health Group, Inc. reported for 2022 q3
SEC form 6
2022-11-08 16:18 ET
LifeStance Health Group, Inc. published news for 2022 q3
SEC form 8
2022-11-08 00:00 ET
LifeStance Health Group, Inc. reported for 2022 q3
SEC form 6
2022-11-03 16:06 ET
LifeStance Health Group, Inc. published news for 2022 q3
SEC form 6
2022-09-09 19:09 ET
LifeStance Health Group, Inc. published news for 2022 q2
SEC form 6
2022-09-08 09:16 ET
LifeStance Health Group, Inc. published news for 2022 q2
SEC form 10
2022-08-10 16:37 ET
LifeStance Health Group, Inc. reported for 2022 q2
SEC form 10
2022-08-10 00:00 ET
LifeStance Health Group, Inc. published news for
SEC form 6
2022-08-09 16:19 ET
LifeStance Health Group, Inc. published news for 2022 q2
SEC form 8
2022-08-09 00:00 ET
LifeStance Health Group, Inc. reported for 2022 q2
SEC form 6
2022-06-02 16:16 ET
LifeStance Health Group, Inc. published news for 2022 q1
SEC form 6
2022-05-24 16:27 ET
LifeStance Health Group, Inc. published news for 2022 q1
SEC form 6
2022-05-23 16:52 ET
LifeStance Health Group, Inc. published news for 2022 q1
SEC form 10
2022-05-11 16:10 ET
LifeStance Health Group, Inc. reported for 2022 q1
SEC form 10
2022-05-11 00:00 ET
LifeStance Health Group, Inc. reported for 2022 q1
SEC form 6
2022-05-09 16:19 ET
LifeStance Health Group, Inc. published news for 2022 q1
SEC form 6
2022-04-21 16:39 ET
LifeStance Health Group, Inc. published news for 2022 q1
SEC form 10
2022-03-17 16:21 ET
LifeStance Health Group, Inc. published news for 2021 q4
SEC form 10
2022-03-17 00:00 ET
LifeStance Health Group, Inc. published news for 2021 q4
SEC form 6
2022-03-10 16:21 ET
LifeStance Health Group, Inc. published news for 2021 q4
SEC form 8
2022-03-10 00:00 ET
LifeStance Health Group, Inc. published news for 2021 q4
SEC form 10
2021-11-10 16:25 ET
LifeStance Health Group, Inc. published news for 2021 q3
SEC form 10
2021-11-10 00:00 ET
LifeStance Health Group, Inc. published news for 2021 q3
SEC form 6
2021-11-08 16:19 ET
LifeStance Health Group, Inc. published news for 2021 q3
SEC form 8
2021-11-08 00:00 ET
LifeStance Health Group, Inc. published news for 2021 q3
SEC form 6
2021-08-26 07:34 ET
LifeStance Health Group, Inc. published news for 2021 q2
SEC form 6
2021-08-24 19:04 ET
LifeStance Health Group, Inc. published news for 2021 q2
SEC form 10
2021-08-12 00:00 ET
LifeStance Health Group, Inc. published news for 2021 q2
SEC form 10
2021-08-11 20:53 ET
LifeStance Health Group, Inc. published news for 2021 q2
SEC form 6
2021-08-11 16:20 ET
LifeStance Health Group, Inc. published news for 2021 q2
SEC form 8
2021-08-11 00:00 ET
LifeStance Health Group, Inc. published news for 2021 q2
SEC form 6
2021-06-29 17:22 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-29 17:19 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-29 17:11 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-16 17:34 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-16 16:50 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-16 16:47 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-15 16:31 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 21:59 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 21:48 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 21:47 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 21:45 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 21:45 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 21:43 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 21:42 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 21:42 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 21:40 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 21:40 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 21:38 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 21:38 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 21:35 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 21:35 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 21:34 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 21:34 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 21:03 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 21:01 ET
LifeStance Health Group, Inc. published news for 2021 q1
SEC form 6
2021-06-10 20:58 ET
LifeStance Health Group, Inc. published news for 2021 q1